Abstract
An assay method for the simultaneous determination of ampicillin (AMP) and cloxacillin (CLOX) from pharmaceutical preparations has been developed for assessment of product quality. It utilizes isocratic HPLC employing an ion-pairing solvent system. The chromatographic conditions comprised a reversed-phase C18 column (100 × 2 mm id) with a mobile phase of acetonitrile–20 mmol l–1 aqueous phosphate buffer (15 + 85) of pH 2.0 incorporating 100 mmol l–1 sodium dodecyl sulfate. The flow rate was 0.4 cm3 min–1 and UV detection was used at 230 nm. A photodiode array detector was used for examination of peak homogeneity. The method has been validated according to current guidelines including assay of pharmacopoeial standard Ampiclox capsules, syrups and neonatal suspensions. In addition to determination of the active ingredients, AMP and CLOX, the method is capable of simultaneously detecting manufacturing precursors and acid hydrolysis decomposition products of both drugs.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
